|Articles|August 21, 2009

Extending Calibrations for Near-Infrared Assay of Tablets Using Synthetic Modeling and Variance from Placebos - Foss Whitepaper

External Link - article-620797.pdf

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!

Trending on Pharmaceutical Technology

Extending Calibrations for Near-Infrared Assay of Tablets Using Synthetic Modeling and Variance from Placebos - Foss Whitepaper

Newsletter

Related Content

FDA, Duke University Planning Epinephrine Access Workshop for December

Dosage Form Innovations: A CPHI Frankfurt Conversation with Lonza’s Frank Romanski, Part One

Challenges, Innovations, and Future Outlook of Biologics Formulations

How ALK's UK-Approved Nasal Spray Changes the R&D Model for Acute Emergency Treatment

Test Your Knowledge: Patient-Centric Care Through Oral Liquid Delivery

Trending on Pharmaceutical Technology

Lilly Launches UK Trial of Weight-Loss Drug as US Price Drops

BirchBioMed’s Idiopathic Pulmonary Fibrosis Treatment Receives Orphan Drug Designation

Batch Certification for New Manufacturing Technologies: The Qualified Person Role in a Digital Environment

FDA Deploys Agentic AI Capabilities for Agency Staff

How a “Plan, Prevent, Prove” Approach Helps Avoid Facility and Equipment Problems